Tri Locum Partners LP Merck & Co., Inc. Transaction History

Tri Locum Partners LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$113.24 - $131.95 $13.5 Million - $15.7 Million	119,200 New	119,200 $15.7 Million
Q1 2023 May 15, 2023	SELL	$102.94 - $114.86 $1.3 Million - $1.46 Million	-12,670 Reduced 9.98%	114,242 $12.2 Million
Q4 2022 Feb 14, 2023	BUY	$87.44 - $112.11 $11.1 Million - $14.2 Million	126,912 New	126,912 $14.1 Million
Q4 2021 Feb 14, 2022	SELL	$72.28 - $90.54 $13.1 Million - $16.5 Million	-181,765 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$71.68 - $78.83 $13 Million - $14.3 Million	181,765 New	181,765 $13.7 Million
Q1 2021 May 17, 2021	SELL	$68.86 - $81.11 $250,030 - $294,510	-3,631 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$71.77 - $79.65 $260,596 - $289,209	3,631 New	3,631 $297,000

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Tri Locum Partners LP, based on Form 13F filings with the SEC.

Stay updated on Tri Locum Partners LP with notifications on news.